ARTICLE | Company News
InVivo Therapeutics management update
March 3, 2014 8:00 AM UTC
InVivo Therapeutics Holdings Corp. (OTCBB:NVIV), Cambridge, Mass. Business: Neurology Hired: Thomas Ulich as CSO, formerly EVP of R&D at ConjuChem Biotechnologies Inc. ...